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Abstract:  1 
Most transcriptional activity of exponentially growing cells is carried out by the RNA 2 
Polymerase I (Pol I), which produces a ribosomal RNA (rRNA) precursor. In budding yeast, 3 
Pol I is a multimeric enzyme with 14 subunits. Among them, Rpa49 forms with Rpa34 a Pol 4 
I-specific heterodimer (homologous to PAF53/CAST heterodimer in human Pol I), which 5 
might be responsible for the specific functions of the Pol I. Previous studies provided insight 6 
in the involvement of Rpa49 in initiation, elongation, docking and releasing of Rrn3, an 7 
essential Pol I transcription factor. Here, we took advantage of the spontaneous occurrence of 8 
extragenic suppressors of the growth defect of the rpa49 null mutant to better understand the 9 
activity of Pol I. Combining genetic approaches, biochemical analysis of rRNA synthesis and 10 
investigation of the transcription rate at the individual gene scale, we characterized mutated 11 
residues of the Pol I as novel extragenic suppressors of the growth defect caused by the 12 
absence of Rpa49. When mapped on the Pol I structure, most of these mutations cluster 13 
within the jaw-lobe module, at an interface formed by the lobe in Rpa135 and the jaw made 14 
up of regions of Rpa190 and Rpa12. In vivo, the suppressor allele RPA135-F301S restores 15 
normal rRNA synthesis and increases Pol I density on rDNA genes when Rpa49 is absent.  16 
Growth of the Rpa135-F301S mutant is impaired when combined with exosome mutation 17 
rrp6∆ and it massively accumulates pre-rRNA. Moreover, Pol I bearing Rpa135-F301S is a 18 
hyper-active RNA polymerase in an in vitro tailed-template assay. We conclude that wild-19 
type RNA polymerase I can be engineered to produce more rRNA in vivo and in vitro. We 20 
propose that the mutated area undergoes a conformational change that supports the DNA 21 
insertion into the cleft of the enzyme resulting in a super-active form of Pol I. 22 
  23 
Author summary:  1 
The nuclear genome of eukaryotic cells is transcribed by three RNA polymerases. RNA 2 
polymerase I (Pol I) is a multimeric enzyme specialized in the synthesis of ribosomal RNA. 3 
Deregulation of the Pol I function is linked to the etiology of a broad range of human 4 
diseases. Understanding the Pol I activity and regulation represents therefore a major 5 
challenge. We chose the budding yeast Saccharomyces cerevisiae as a model, because Pol I 6 
transcription apparatus is genetically amenable in this organism. Analyses of phenotypic 7 
consequences of deletion/truncation of Pol I subunits-coding genes in yeast indeed provided 8 
insights into the activity and regulation of the enzyme. Here, we characterized mutations in 9 
Pol I that can alleviate the growth defect caused by the absence of Rpa49, one of the subunits 10 
composing this multi-protein enzyme. We mapped these mutations on the Pol I structure and 11 
found that they all cluster in a well-described structural element, the jaw-lobe module. 12 
Combining genetic and biochemical approaches, we showed that Pol I bearing one of these 13 
mutations in the Rpa135 subunit is able to produce more ribosomal RNA in vivo and in vitro. 14 
We propose that this super-activity is explained by structural rearrangement of the Pol I 15 
jaw/lobe interface. 16 
  17 
Introduction  1 
The nuclear genome of eukaryotic cells is transcribed by three RNA polymerases [1]. RNA 2 
polymerase II (Pol II) transcribes most of the genome and is responsible for all messenger 3 
RNA production. RNA polymerases III and I are specialized in the synthesis of a limited 4 
number of transcripts. RNA polymerase III (Pol III) produces small structured RNAs, 5 
including tRNAs and the 5S ribosomal RNA. RNA polymerase I (Pol I) produces a single 6 
transcript, the large polycistronic precursor (35S pre-rRNA in yeast; 47S in human), which 7 
constitutes the first step of ribosome biogenesis. Pre-rRNA is then processed by multiple 8 
successive steps into the mature rRNAs (25S, 18S, and 5.8S in yeast; 28S, 18S and 5.8S in 9 
human). Despite producing a single transcript, Pol I is by far the most active eukaryotic RNA 10 
polymerase, responsible for up to 60% of the total transcriptional activity in exponentially 11 
growing cells [2]. The strongly transcribed rRNA genes can be visualized using the DNA 12 
spread method developed by Miller et al, 1969, in which the 35S rRNA genes (rDNA) exhibit 13 
a “Christmas tree” configuration, with up to 120 polymerases per transcribed gene [3].  14 
The full subunit composition and structural data are now available for the three nuclear RNA 15 
polymerases of the budding yeast Saccharomyces cerevisiae [4,5][6,7]. Pol I contains a core 16 
of shared or homologous subunits that are largely conserved in eukaryotes and archaea, as for 17 
the other two nuclear RNA polymerases [8]. The two largest subunits (Rpa190 and Rpa135) 18 
form the DNA-binding cleft that carries the catalytic center. Rpb5, Rpb6, Rpb8, Rpb10, and 19 
Rpb12 are shared with Pol II and Pol III, whereas Rpc40 and Rpc19 are only shared with Pol 20 
III. This nine-subunit core is associated with the stalk, a structure formed in Pol I by the 21 
heterodimeric complex Rpa43/Rpa14, which is involved in docking the essential Rrn3 22 
initiation transcription factor to the enzyme [9–12]. The Pol I-Rrn3 complex interacts with 23 
promoter bound factors, the core factor (CF), forming the initially transcribing complex (ITC) 24 
[13–16]. Additionally, Pol I and Pol III contain subunits that are functionally and structurally 25 
related to Pol II-specific basal transcription factors, called the "Built-in Transcription Factors" 1 
[17–19]. Their presence in Pol I and Pol III results in a higher number of subunits, from 12 2 
subunits in Pol II, to 14 and 17 for Pol I and Pol III respectively, and correlates with 3 
substantial transcript production from a few genes [8]. The heterodimer formed by Rpa34 and 4 
the N-terminal domain of Rpa49 (Rpa49Nt) in Pol I (equivalent to Rpc53 and Rpc37 in Pol 5 
III) is related to the basal transcription factor TFIIF, and stimulates endogenous transcript 6 
cleavage activity [18,20,21]. Rpc34 in Pol III and the Rpa49 C-terminal domain (Rpa49Ct) 7 
bear a tandem winged helix domain similar to TFIIE, also named A49tWH [18,20]. Rpa49Ct 8 
binds upstream DNA [15,22] and is involved in initiation and elongation [18,23]. Finally, 9 
Rpa12 in Pol I and Rpc11 in Pol III harbour a C-terminal domain involved in stimulating 10 
endogenous transcript cleavage activity, similar to that of TFIIS for Pol II [17,24].  11 
Yeast genetic studies of Pol III and Pol I “Built-in Transcription Factors” have revealed 12 
striking differences, despite their clear similarities. Each Pol III subunit is essential, but none 13 
of the Pol I “Built-in Transcription Factors" is required for cell growth. Lack of Rpa34 or 14 
invalidation of Rpa49Nt, by removing the TFIIF-like heterodimer, has no growth effect in 15 
vivo [18,25,26]. In contrast, full or C-terminal deletion of RPA49 leads to a strong growth 16 
defect at all temperatures, which is more severe below 25°C [18,26,27]. Full deletion of 17 
RPA12 leads to a strong growth defect at 25 and 30°C, and is lethal at higher temperatures 18 
[28]. Lack of the C-terminal extension of Rpa12 abolishes stimulation of intrinsic cleavage, 19 
without any detectable growth defect [17,24]. Finally, yeast strains carrying the triple deletion 20 
of RPA49, RPA34 and RPA12 are viable, but accumulate the growth defects associated with 21 
each of the single mutants [25].  22 
Pol I is functional in the absence of Rpa49, but shows well-documented initiation and 23 
elongation defects, both in vivo and in vitro [23,26,27,29–31]. Restoration of active rRNA 24 
synthesis, in the absence of Rpa49, has been used to identify factors involved in initiation and 25 
elongation, such as Hmo1 and Spt5 [26,30,32]. Here, we made use of the spontaneous 1 
occurrence of extragenic suppressors of the growth defect of the rpa49 null mutant [27] to 2 
better understand the activity of Pol I. We showed that the suppressing phenotype was caused 3 
by specific point mutations in the two largest Pol I subunits, Rpa190 and Rpa135. We 4 
identified a small area around Phe301 in subunit Rpa135, at an interface formed by the lobe in 5 
Rpa135 and the jaw made up of regions of Rpa190 and Rpa12, where most mutations cluster. 6 
Characterizing the Rpa135-F301S allele, we showed in an in vitro assay, that such Pol I 7 
mutant is more active than the wild-type enzyme. In vivo, overproduction of rRNA by Pol I 8 
bearing the Rpa135-F301S mutation was observed in backgrounds where the nuclear 9 
exosome activity is impaired by RRP6 deletion. 10 
11 
Results 1 
Isolation of extragenic suppressor mutants of the growth defect in absence of Rpa49 2 
We characterized extragenic suppressors of the RPA49 deletion to better understand how cell 3 
growth is achieved in the absence of Rpa49. RPA49 full-deletion mutants show a strong 4 
growth defect at 30°C and are unable to grow at 25°C. However, spontaneous suppressors 5 
have been previously observed [27]. We quantified the frequency of occurrence of individual 6 
clones able to grow at 25°C. There was a low frequency of colony occurrence, comparable 7 
with the spontaneous mutation rate of a single control gene (CAN1; < 5.10-6). We isolated 8 
more suppressors after irradiating the cells with UV light. UV irradiation, resulting in a 9 
survival rate of about 50%, increased the frequency of suppressor mutations by approximately 10 
10-fold. We identified clones that grew at 25°C after three days and selected individual 11 
colonies, called SGR for Suppressor of Growth Defect of RPA49 deletion, with various 12 
growth rates. We ranked SGR from 1 to 186 based on their growth rates at 25°C; SGR1 had a 13 
growth rate comparable to the wild-type (WT) condition (Fig. 1A). We crossed the 186 SGR 14 
clones with a strain of the opposite mating type bearing the deletion of RPA49 to obtain 15 
diploid cells homozygous for the RPA49 deletion and heterozygous for each suppressor. The 16 
restoration of growth of the diploids at 25°C showed that all suppressor phenotypes obtained 17 
were fully or partially dominant. We focused on the most efficient suppressor clones, SGR1 18 
and SGR2, and performed tetrad analysis to follow segregation of the observed suppression 19 
phenotype. Each suppressor phenotype was linked to a single locus in the genome and SGR 20 
mutants had no strong growth defect (SGR1 in Fig. 1A). We used global genomic mapping of 21 
SGR1 and SGR2, derived from "genetic interaction mapping" (GIM) methods [33] (Materials 22 
and Methods; S1 Fig), and found a genomic linkage with genes encoding the two largest Pol I 23 
subunits: RPA135 for SGR1 and RPA190 for SGR2 (S1 Fig). Sequencing of the genomic 24 
DNA revealed that SGR1 bears a double mutation, whereas SGR2 bears a single one 25 
(RPA135-I218T/R379K and RPA190-A1557V alleles, respectively). Furthermore, we 1 
identified an additional mutant, SGR3, in RPA135 (RPA135-R305L). The heterogeneity of the 2 
growth induced by strong UV mutagenesis prevented suppressor cloning from the 183 other 3 
SGR clones.  4 
We next used the dominant phenotype of these suppressors to isolate more alleles, which 5 
suppress the deletion phenotype of RPA49 in RPA190 and RPA135. We constructed a library 6 
of randomly generated mutants (see Materials and Methods) by propagating plasmids bearing 7 
WT RPA135 or RPA190 in a mutagenic E. coli strain. After phenotypic selection of rpa49∆ 8 
mutants bearing a mutagenized Rpa190 or Rpa135 subunit at 25°C, each plasmid bearing a 9 
suppressor allele was extracted, sequenced, and re-transformed into yeast to confirm the 10 
suppressor phenotype. We thus isolated nine novel alleles of RPA190 and thirteen of RPA135 11 
that were able to restore growth of rpa49 deletion mutant at 25°C (S1 Table). We evaluated 12 
the suppression strength based on growth restoration relative to WT at 25°C, as for the SGR 13 
strains. Suppressor alleles obtained by mutagenesis of RPA190 or RPA135, more effective 14 
than SGR1, 2, or 3 were identified (S1 Table). In conclusion, we identified 22 novel alleles of 15 
genes coding for the two largest Pol I subunits as extragenic suppressors of the rpa49∆-16 
associated growth defect. 17 
rpa190 and rpa135 mutant alleles can bypass the need of RPA49 for optimal growth 18 
The growth of the strains bearing one of six suppressor alleles (RPA190-E1274K, RPA190-19 
C1493R, RPA190-L1262P, RPA135-R379G, RPA135-Y252H, and RPA135-F301S) was 20 
evaluated by a 10-fold dilution test (Fig. 1B), showing significant suppression by all in the 21 
absence of Rpa49. In previous genetic studies, other genetic backgrounds that alleviate the 22 
growth defect of rpa49∆ at 25°C were isolated: rpa43-35,326 [26], decreased rDNA copy 23 
number [29], Hmo1 over-expression [30], or Spt5 truncations [32]. For all these mutants, 24 
rRNA synthesis was only partially restored in the absence of Rpa49 and significant 25 
transcription defects remained. Here, we focused on the RPA135-F301S allele, the most 1 
effective growth suppressor of the RPA49 deletion: the rpa49∆ RPA135-F301S double mutant 2 
grew almost as well at 25°C as the WT strain (Fig. 1B).  3 
We sought further insight into the effect of the suppressors by integrating the RPA135-F301S 4 
point mutation into the endogenous gene in three genetic backgrounds: WT, rpa49∆ (full 5 
deletion), or rpa49∆Ct. Note that yeast bearing rpa49∆Ct or rpa49∆ full-deletion have a 6 
similar growth defect, but have different Pol I subunits composition [26,27]. In the absence of 7 
Rpa49, Rpa34 does not associate with transcribing Pol I while in strains bearing the rpa49∆Ct 8 
allele, Rpa34 and Rpa49Nt remain associated with the polymerase [26,27]. The growth rate 9 
was determined in each of these yeast strains at 30°C, in the presence or absence of RPA135-10 
F301S. The suppressor allele RPA135-F301S had no effect on growth in the WT strain 11 
(doubling time of 102 min). The doubling time was 180 min for the rpa49∆ strain and 12 
RPA135-F301S restored growth to a doubling time of 135 min. We observed similar 13 
suppression on the rpa49∆Ct background. 14 
Most suppressors mutations are clustered in the jaw-lobe module 15 
Structural data are now available for Pol I in an inactive form [4,5], in complex with Rrn3 16 
[12,23,34], associated with other initiation factors [13–15], in elongating forms [22,35], and 17 
in the paused state [36](Fig. 2A). We mapped Rpa135 and Rpa190 residues that suppress the 18 
growth defect of the mutant strain rpa49∆ onto the structure of WT Pol I in which the full 19 
structure of Rpa49 was determined [15] (Fig. 2B). Most of the suppressor mutations, which 20 
provided growth recovery (S1 table), appeared to be clustered at a specific interface between 21 
the two largest subunits, Rpa190 and Rpa135 (Fig. 2B), between the lobe (Rpa135 - salmon) 22 
and the jaw (Rpa190 - blue). In RPA135, we found five suppressor mutations, which modify a 23 
small region of 60 residues within the lobe domain (S2 Fig). Note that in this region, three 24 
amino acids "DSF" (D299, S300, F301), which are conserved among eukaryotic species, are 25 
all mutated in suppressors (S2 Fig). Substituted residues likely result in destabilization of this 1 
interface, suggesting a specific rearrangement of the interface lobe/jaw in each mutant. The 2 
jaw is also characterized by the presence of a β-strand in the structure of Rpa12 (Rpa12 - 3 
yellow: residues 46-51, Fig. 2B) that, along with four β-strands in Rpa190, forms a five-4 
stranded anti-parallel β-sheet. The Rpa12 β-strand faces the Rpa135 lobe domain (residue 252 5 
to 315 of Rpa135 - salmon), in which six independent mutations were found, including 6 
RPA135-F301S.  7 
To evaluate the implication of Rpa12 in suppression, we then tested whether mutated alleles 8 
of RPA12 could behave as suppressors. We generated a library of randomly mutagenized 9 
RPA12, and screen for RPA12 alleles able to correct rpa49∆ growth defect at 25°C. Two 10 
dominant alleles (RPA12-S6L and RPA12-T49A) indeed efficiently suppressed the growth 11 
defect of rpa49∆ and of rpa49∆Ct to a similar extend (Fig. 2D, just shown for rpa49∆Ct). 12 
RPA12-S6L and RPA12-T49A obtained by random mutagenesis are specifically located in the 13 
"hotspot" at the jaw/lobe interface. Threonine 49 of Rpa12 is located on the β-strand (Fig. 14 
2C), facing residues D299, S300, and F301 of Rpa135, and Rpa190-E1274 (Fig. 2B). The 15 
second mutation, RPA12-S6L, is located in the N-terminal domain of Rpa12 (Fig. 2C). 16 
In conclusion, all point mutations in Rpa190, Rpa135, and Rpa12 detected in the hotspot 17 
domain of the jaw/lobe interface substitute for RPA49 in vivo. 18 
 19 
Pol I bearing Rpa135-F301S or Rpa12-S6L restores efficient rRNA synthesis and Pol I 20 
occupancy on rRNA genes in the absence of Rpa49Ct in vivo  21 
We used yeast mutant cells with a low (about 25 copies, +/- 3 copies) and stabilized (fob1∆) 22 
number of rDNA repeats to better associate the growth phenotype of RPA135-F301S or 23 
RPA12-S6L allele to rRNA synthesis activity and Pol I density on transcribed genes in vivo. 1 
This genetic background is the best suited to study variations in the number of polymerase 2 
molecules per rRNA gene because it has a low number of rDNA copies, almost all in the 3 
active state with a very high Pol I loading rate [29,37,38]. We generated five strains in this 4 
low copy background (bearing single mutations; rpa49∆Ct, RPA135-F301S, RPA12-S6L and 5 
double mutants combining rpa49∆Ct with RPA135-F301S or RPA12-S6L alleles) and 6 
determined their doubling time (Fig. 3A) and de novo synthesis of rRNA (Fig. 3B). Note that 7 
rDNA copies number is similar between strains, as indicated by chromosome XII size in 8 
pulse-field gel electrophoresis (S3 Fig). The presence of the RPA135-F301S allele in Pol I 9 
effectively compensated the growth defect caused by the absence of C-terminal part of Rpa49 10 
in this background.  11 
Labelling of the nascent rRNA was performed using a 2-min pulse with 3H adenine. We 12 
performed the labelling in three independent cultures because of heterogeneity due to random 13 
occurrence of suppressors in cell cultures of the rpa49∆Ct mutant. When compared to a WT 14 
strain, RNA precursors synthesis was reduced approximately five-fold for rpa49ΔCter, even 15 
under permissive conditions (30°C) (compare Fig. 3B, lane 1 to lanes 2 to 4). Pol I activity in 16 
the presence of RPA135-F301S, with or without Rpa49Ct, was similar to that of the WT 17 
enzyme (Fig. 3B, lane 5 and 6). Similarly, RPA12-S6L partially restored Pol I activity in the 18 
absence of Rpa49Ct (compare Fig. 3B, lanes 7 and 8). Thus, RPA135-F301S and RPA12-S6L 19 
appeared to largely restore rRNA production in the absence of C-terminal part of Rpa49. 20 
To get insight in Pol I activity in suppressors strains, we combined the rRNA synthesis 21 
quantification with the analysis of the Pol I distribution along the rRNA genes. We evaluated 22 
Pol I density on transcribed genes by performing Miller spreads, the only technique that 23 
currently allows the counting of individual Pol I molecules on a single rRNA genes [3,29]. 24 
Using Miller spreads, we previously showed that full deletion of rpa49 resulted in a three-fold 25 
decrease of Pol I density per gene [3,29]. We show here that strain expressing the rpa49∆Ct 1 
allele results in a four-fold decrease of Pol I density per gene, with about 21 Pol I detected per 2 
gene, as compared to about 91 detectable in WT condition (Fig. 2C). Expression of the 3 
RPA135-F301S, WT for RPA49, had no detectable influence on Pol I density (Fig. 3C, 4 
RPA135-F301S). In contrast to strain rpa49∆Ct, double mutant rpa49∆Ct RPA135-F301S or 5 
rpa49∆Ct RPA12-S6L showed significantly higher Pol I occupancy (46 and 43 respectively 6 
instead of 21 Pol I molecules per gene). Using ChIP, we reproduced that Pol I occupancy in 7 
absence of Rpa49Ct is drastically reduced [26]. We confirmed Miller spread quantification, in 8 
which RPA135-F301S significantly increased Pol I occupancy in absence of Rpa49Ct, 9 
although not to WT level (Fig. 3D). 10 
 11 
Overall, these results show that the presence of the RPA135-F301S, or to a lesser extend 12 
RPA12-S6L allele, in a strain lacking C-terminal part of Rpa49 restores rRNA synthesis to 13 
WT levels. However, Pol I density on rRNA genes is only partly restored, indicative of an 14 
improved transcription initiation, or increased stability of elongating Pol I in absence of 15 
Rpa49Ct. 16 
Genetic interplay between suppressors alleles and Pol I domains 17 
Extensive genetic characterization of Pol I subunits together with recent structural analysis 18 
have provided insight in their involvement in catalytic steps (initiation, pause release or 19 
termination). To investigate suppression mechanism, we then decided to explore which 20 
domains or subunits of Pol I are required for the suppression to occur. We tested deletion of 21 
RPA14, RPA34 or RPA12, and of RPA190 alleles (rpa190∆loop) coding for Rpa190 lacking 22 
specific domain. The structure of Rpa190 revealed the presence of an extended loop inside the 23 
DNA-binding cleft folded in a "expander/DNA mimicking loop" conformation when Pol I is 24 
in an inactive, dimeric form [4,5]. This loop is inserted in the jaw domain of Rpa190 (Fig. 25 
2B), in the vicinity of the mutation hotspot. A small deletion of this Rpa190 domain (1361-1 
1390) resulted in a slight slow-growth phenotype [4]. We generated a larger deletion allele, 2 
rpa190∆loop (deletion of residues 1342-1411 of Rpa190), and observed no associated growth 3 
defect (Fig. 4A). We were unable to generate a viable double mutant when combining this 4 
mutation with the rpa49 full deletion. Thus, the DNA-mimicking loop is required for Pol I 5 
activity in the absence of Rpa49. We next tested whether deletion of this loop influences the 6 
suppression by the RPA135-F301S allele. Note that the rpa190∆loop combined with RPA135-7 
F301S had no growth phenotype. There was no difference in the growth of the rpa49∆ 8 
RPA135-F301S double mutant and that of the triple mutant rpa49∆ RPA135-F301S 9 
rpa190∆loop (Fig. 4A). Thus, the expander/DNA mimicking loop of Rpa190 is not required 10 
for suppression, but is required for the viability of the rpa49 deletion mutant. 11 
Rpa34 forms a heterodimer with Rpa49Nt, and Rpa14 is essential in absence of Rpa49. We 12 
then introduced RPA135-F301S in yeast strains lacking either Rpa34 or Rpa14 (Fig. 4B and 13 
C). Growth of RPA135-F301S/rpa34∆ and RPA135-F301S/rpa14∆ double mutants were not 14 
different from that of the single mutants. However, RPA135-F301S suppressed the growth 15 
defect of the viable double mutant, rpa34∆ rpa49∆ (Fig. 4B). The double deletion mutant 16 
lacking both Rpa49 and Rpa14 was not viable [25]. Introduction of the suppressor RPA135-17 
F301S, by genetic crossing, resulted in a triple mutant (rpa14∆ rpa49∆ RPA135-F301S) that 18 
could grow, but slower than WT (Fig. 4C). We conclude that RPA135-F301S does not require 19 
Rpa14 or Rpa34 for the suppression to occur. 20 
We next evaluated which part of Rpa12 subunit was required for the suppression to occur 21 
(Fig. 5). First, we evaluated growth of rpa12 alleles when combined with rpa49 deletion. The 22 
C-terminal region of Rpa12 (TFIIS-like) is inserted towards the active center of Pol I to 23 
stimulate intrinsic cleavage activity but is displaced during productive initiation and 24 
elongation steps. C-terminal deletion of Rpa12 resulted in normal growth [24] (Fig. 5A- lane 25 
2), although the rpa12∆Ct allele is unable to stimulate cleavage activity in vitro [17]. Full 1 
deletion of RPA12 led to a heterogeneous growth phenotype when propagated at 30°C. To 2 
overcome this heterogeneity, we constructed a strain with RPA12 under the control of the 3 
regulatable pGAL promoter. Depletion of Rpa12 on glucose containing medium, like full 4 
RPA12 deletion, resulted in a slight growth defect at 25°C, which was stronger at 30°C [28] 5 
(Fig. 5A-lane 3). In contrast, RPA49 deletion resulted in a growth defect at 30°C, which was 6 
stronger at 25°C [27] (Fig. 5A-lane 4). Combining rpa12∆Ct with rpa49∆ resulted in a mild 7 
synergistic phenotype, with a stronger growth defect at both 25°C and 30°C (Fig. 5A - lane 8 
5). The double mutant lacking both full Rpa12 and Rpa49 subunits was viable, but had a 9 
major growth defect [25] (Fig. 5A - lane 6).  10 
Secondly, in double rpa12/rpa49 mutants, we tested the expression of the suppressors alleles, 11 
which were isolated (RPA12-S6L, RPA12-T49A or RPA135-F301S). We explored whether the 12 
C-terminal extension of Rpa12 was necessary for suppression of the rpa49∆ phenotype. We 13 
introduced the Rpa12 C-terminal truncation into the strain bearing both rpa49∆ and 14 
suppressor allele RPA12-S6L. RPA12-S6L resulted in similar suppression of the rpa49∆ 15 
growth defect (Fig. 5B). We then introduced the RPA135-F301S allele in strains lacking 16 
Rpa49 with or without the entire Rpa12 subunit and assessed the suppression phenotype at 17 
25°C (Fig. 5C). The growth defect of rpa49∆ was completely suppressed by the RPA135-18 
F301S allele when Rpa12 was expressed (Fig. 5C, left panel), whereas suppression mediated 19 
by RPA135-F301S was not detected in the absence of Rpa12 (Fig. 5C, middle panel). After 10 20 
days, rpa49∆ rpa12∆ double mutant behaved exactly the same with or without the RPA135-21 
F301S allele, demonstrating that suppressor allele has no effect in absence of Rpa12 (Fig. 5C, 22 
right panel).  23 
In conclusion, we show that RPA135-F301S suppression of rpa49∆-associated growth defect 24 
does not require Rpa190 DNA mimicking loop, Rpa34, or Rpa14. Rpa12 C-terminal portion 25 
involved in stimulating cleavage activity is also not required for suppression. In contrast, 1 
Rpa12 N-terminal domain is required for the suppression to occur.  2 
 3 
In vitro characterization of RNA polymerase I bearing RPA135-F301S  4 
In vitro, C-terminal part of Rpa49 is essential in promoter-dependent transcription assay [23]. 5 
Our in vivo analysis suggests that in RPA135-F301S mutant background, C-terminal part of 6 
Rpa49 is not required for rRNA synthesis. Our hypothesis is that Rpa135-F301S partly 7 
compensates the requirement for C-terminal part of Rpa49 in initiation. We used the 8 
promoter-dependent in vitro transcription system and tailed-template system to assess this 9 
hypothesis (Fig. 6A and B). Results were strikingly different when using promoter-dependent 10 
or tailed-template systems. After depletion of Rpa49, purified Pol I lacks both Rpa34 and 11 
Rpa49 subunits and is the so-called Pol A* complex [23,25,31]. Pol I lacking subunits 12 
Rpa49/Rpa34 (Pol A*, Fig. 6A lane 2) was almost inactive in promoter-dependent assay 13 
when compared to wild-type Pol I (WT) or Pol I bearing Rpa135-F301S (Fig. 6A, lane 1 and 14 
3). Note that addition of recombinant Rpa34/Rpa49, Rpa49Ct alone or Rpa34/Rpa49N-ter 15 
stimulated transcription by Pol A* [23]; similarly, recombinant Rpa34/Rpa49 stimulated 16 
transcription of Pol A* bearing Rpa135-F301S (S4 Fig). Ruling out our hypothesis, Pol I 17 
bearing Rpa135-F301S did not restore promoter-dependent activity of RNA Pol I lacking 18 
Rpa49 (Fig. 6A lane 4). We next tested RNA synthesis in a tailed-template system. Pol I 19 
lacking Rpa34/Rpa49 was partly deficient in tailed template assay (Fig. 6B, lane 2) [23]. 20 
Interestingly, in this promoter-independent assay, we clearly observed that the RNA synthesis 21 
by the polymerase bearing Rpa135-F301S was increased compared to one with the WT 22 
polymerase (Fig. 6B compare lane 1 to 3). Moreover, Pol I bearing Rpa135-F301S fully 23 
restored tailed template production of RNA Pol I lacking Rpa49 (Fig. 6B, lane 4). We 24 
conclude that in the in vitro promoter-dependent transcription assay, RPA135-F301S 25 
suppressor does not correct initiation defect due to the absence of Rpa49. However, in 1 
presence of Rpa135-F301S, a more efficient polymerase is engineered, able to produce more 2 
ribosomal RNAs from DNA tailed template. 3 
 4 
In vivo characterization of RNA polymerase I bearing Rpa135-F301S 5 
In vitro, Pol I bearing Rpa135-F301S is over-producing RNA compared to WT. However in 6 
vivo, we could not reveal increased production of rRNA (2 min pulse labelling, see Fig. 3B). 7 
Pre-rRNAs which are not properly folded into pre-ribosome are targeted to degradation by the 8 
3' to 5' exoribonucleolytic activity of the exosome [39]. We hypothesized that overproduced 9 
rRNAs in RPA135-F301S mutant background could be targeted by the nuclear exosome. 10 
Rrp6, part of the nuclear exosome complex, was deleted in a WT strain and in a strain bearing 11 
RPA135-F301S mutation. We observed a strong synergistic growth defect in strain bearing 12 
both RPA135-F301S and the deletion of RRP6 (S5 Fig). Northern blot analysis (Fig. 7A) 13 
showed that accumulation in RPA135-F301S single mutant was indistinguishable from the 14 
WT for all RNA probed. rrp6∆ single mutant accumulates 23S and 35S (pre-)rRNA [40,41] 15 
and in correlation with the growth defect of the double mutant RPA135-F301S rrp6∆, we 16 
could observe a 2-fold increase in 35S and 23S (pre-)rRNA accumulation as compared to 17 
rrp6Δ. Accumulation of 35S and 23S could indicate an increase of RNA production, or a 18 
defect in early maturation steps. We decided to directly assess over-expression of (pre-)rRNA 19 
using short in vivo labelling experiments (40 seconds). As previously reported with very short 20 
pulse labelling, accumulation of 20S rRNA is barely detectable, while 27SA and 35S are 21 
already accumulated [42]. We could detect a strong accumulation of newly synthesized (pre-) 22 
rRNA in the double mutant RPA135-F301S rrp6∆ compared to WT, RPA135-F301S or rrp6∆ 23 
strains. Note that increased background signal could indicate an accumulation of partially 24 
degraded, abortive transcripts or elongating rRNA transcript of various sizes. These results 25 
suggests that rRNA are over-expressed in strain bearing RPA135-F301S, but are quickly 1 
decayed by Rrp6. We confirmed this observation by evaluating ongoing transcription 2 
independently of decay machinery using high-resolution transcriptional run-on (TRO) 3 
analysis (Fig. 7C). Indeed, TRO assay make use of 10% sarkosyl, which permeabilizes cell 4 
membranes, reversibly blocks elongating polymerases and inhibits RNAse activity [43–46]. 5 
Permeabilized cells are then incubated with [α32P]-UTP to resume transcription. 6 
Neosynthesized radiolabeled RNAs are extracted, and used to probe slot-blots loaded with 7 
single strand DNA fragments complementary to rDNA locus. Using incorporation of [α32P]-8 
UTP in the 5S rRNA transcribed by RNA polymerase III as internal control, TRO revealed a 9 
three-fold increase of rRNA transcription in cells bearing RPA135-F301S allele, irrespective 10 
of Rrp6 presence (Fig. 7C). These results confirmed that Pol I bearing Rpa135-F301S is over-11 
producing RNA compared to WT and that over-produced RNAs are targeted for degradation 12 
by the exosome. All together, we concluded that Pol I bearing Rpa135-F301S is a hyper-13 
active RNA polymerase in vivo. 14 
  15 
Discussion 1 
Here, we characterized extragenic suppressors of the growth defect of the rpa49 null mutant 2 
to better understand the activity of Pol I. We showed that altering a very specific area of Pol I 3 
resulted in an enzyme with modified catalytic properties sufficient to restore wild-type growth 4 
in absence of Rpa49.  5 
 6 
Suppressor mutations are not at the Rrn3-Pol I stalk interface 7 
Our previous studies suggested the specific involvement of Rpa49 in the association and 8 
dissociation of initiation factor Rrn3 from the Pol I stalk [26,29]). Here, we show that 9 
genetically modified polymerases lacking Rpa49 or Rpa49Ct, with a single modified residue 10 
in Rpa190, Rpa135, or Rpa12, at a position diametrically to the position that binds to Rrn3, 11 
can initiate transcription and that strains harbouring them grow normally. Moreover, mutant 12 
Pol I with Rpa135-F301S does not restore promoter dependent activity in absence of Rpa49. 13 
We propose that, independently of the important interplay between Rpa49 and Rrn3 during 14 
initiation, Rpa135-F301S can stimulate Pol I activity. 15 
 16 
A novel role of Rpa12 subunit 17 
The Rpa12 subunit is involved in stimulating the intrinsic cleavage activity of Pol I through a 18 
TFIIS-like domain at its C-terminus. Purified Pol I with Rpa12 lacking the C-terminal domain 19 
has no cleavage activity [17]. Furthermore, the C-terminal domain of Rpa12 can contact the 20 
active site of the polymerase in the inactive conformation and is retrieved in both initiation 21 
competent and elongating forms of the polymerase. However, the cleavage activity is re-22 
activated when Pol I is paused [36]. Direct evidence that cleavage is not involved in 23 
suppression of the growth defect came from the experiments showing a fully functional 24 
suppressor phenotype for RPA12∆Ct-S6L, which lacks the domain required for stimulating 1 
cleavage.  2 
The N-terminal domain of Rpa12, at the surface of Pol I, is involved in the recruitment of the 3 
largest subunit, Rpa190 [24] and is required for docking this subunit to the enzyme. A linker 4 
region of Rpa12 connects its N-terminal module (equivalent to the N-terminal domain in the 5 
Pol II subunit Rpb9) at the surface of Pol I to its mobile C-terminal region (TFIIS-like) and is 6 
therefore indirectly required for cleavage. In vitro, purified Pol I that lacks Rpa12 has less 7 
activity than WT Pol I in promoter-dependent transcription assays (S6 Fig). Mutations in 8 
other Pol I domains, such as deletions in the Rpa190-DNA mimicking loop, Rpa34 or Rpa14, 9 
did not influence suppression of the rpa49 deletion growth defect by the RPA135-F301S 10 
allele. In contrast, the Rpa12 linker was absolutely required for efficient suppression. 11 
Accordingly, RPA135-F301S allele was unable to restore efficient growth when Rpa12 was 12 
absent. Thus, Rpa12 and RPA135-F301S likely cooperate in the super-active Pol I enzyme. 13 
Note that rearrangement of Rpa12 have recently be shown to correlate with dissociation of 14 
Rpa49/Rpa34 heterodimer from Pol I, confirming the tight interplay between those subunits 15 
[47]. 16 
Modification of the jaw/lobe interface may facilitate DNA cleft closure  17 
Pol I undergoes major conformational changes during the transcription cycle, mainly affecting 18 
the width of the DNA-binding cleft [48]. During the initiation of transcription, the cleft 19 
aperture narrows from a semi-open configuration, as seen in cryo-EM structures of the 20 
enzyme bound to Rrn3 [12,23,34], to a fully closed conformation observed in transcribing 21 
complexes [13,15] (Fig. 8). This allows gripping of the transcription bubble inside the cleft 22 
(Fig. 8A-B). Following Rrn3 release, DNA binding is further secured, by the Rpa49-linker, 23 
which crosses the cleft from the lobe to the clamp, passing over the downstream DNA, and by 24 
the Rpa49Ct, which binds the upstream DNA in the vicinity of the clamp [15,22]. Therefore, 1 
Rpa49Ct is anchored in a position securing cleft closure (Fig. 8B). 2 
Cleft closure is achieved by the relative movement of two structural units, located on opposite 3 
sides of the cleft, pivot with respect to each other using five hinges [4]. The unit consisting of 4 
the shelf and clamp modules appears to be rigid, whereas the unit comprising the core and 5 
lobe modules, which is in the vicinity of the mutated residues involved in suppression of the 6 
rpa4∆growth defect, undergoes internal rearrangements (S1 Movie). The most prominent 7 
reorganization within this latter unit affects the Rpa190 jaw domain, the outer rim of which 8 
shifts away from the DNA by approximately 3.7 Å, using the lobe/jaw interface as a hinge 9 
(Fig. 8B; blue arrow). This movement also involves the linker region of Rpa12, which 10 
contains a β-strand (residues 46-50) that completes a four-stranded β-sheet in the Rpa190 jaw 11 
domain. As a result, a short α-helix within the Rpa12 linker region shifts by approximately 12 
3.0 Å (Fig. 8B; yellow arrow).  13 
Rearrangements in the jaw made up of regions of Rpa190 and Rpa12 are likely essential to 14 
allow pivoting of the shelf-clamp unit against the core-lobe unit. Without such motion, cleft 15 
closure would be impossible (S1 Movie). Structural analysis suggests that the C-terminal 16 
domain of Rpa49 and its linker domain are involved in securing the closed cleft conformation 17 
[15,22]. Cleft closure is likely destabilized in the rpa49∆ mutant (Fig. 8C). We propose that 18 
Rpa135-F301S or Rpa12-S6L favors DNA capture by increasing the flexibility of the 19 
lobe/jaw/Rpa12 interface of Pol I relative to that of the WT polymerase, facilitating cleft 20 
closure in the absence of Rpa49 (Fig. 8D, red arrow). As shown in vitro, mutant Pol I with 21 
Rpa135-F301S is super-active. In vivo, the increased accumulation of pre-rRNA, detectable in 22 
absence of the nuclear exosome (rrp6∆), is in agreement with the in vitro super-activity. We 23 
propose that Pol I bearing Rpa135-F301S might facilitate cleft closure, in addition to secure 24 
cleft closure by Rpa49. Such mutant enzyme could capture DNA more efficiently than WT 1 
polymerase (Fig. 8E). Alternatively, the mutations could also favour a 'closed cleft' 2 
conformation in the presence of DNA with little impact on flexibility. 3 
 4 
Pol I cleft closure is a limiting step in catalytic cycle  5 
Here, we show that Pol I can be engineered to generate more rRNA. A super-active mutant of 6 
Pol II was already characterized: point mutation in trigger loop (Rpb1-E1103G) leads to 7 
increase RNA polymerization rate, affecting pausing and transcriptional fidelity [49,50]. 8 
Despite a very similar active site organization, an analogous mutation in the Pol I trigger loop 9 
resulted in a very different outcome, as it reduces the elongation rate [51]. Such observations 10 
led to the conclusion that Pol I catalytic cycle is very different than the one of Pol II, with 11 
different rate limiting steps [51–53]. We show here that mutations away of the active center 12 
can lead to a super-active form of Pol I. This difference can stem from wide-open 13 
configuration of the DNA-binding cleft in Pol I compared to other polymerases. We propose 14 
that Pol I cleft opening and closure is a limiting step in the Pol I catalytic cycle. 15 
  16 
Materials and Methods 1 
Construction of plasmids and yeast strains  2 
The oligonucleotides used in this study are listed in S4 Table. Plasmids and details of the 3 
cloning steps are described in S3 Table. Randomly mutagenized RPA190 and RPA135 4 
libraries were obtained by transformation and amplification of pVV190 and pNOY80, 5 
respectively, into XL1-red strains according to the manufacturer’s guidelines (XL1-Red 6 
Competent Cells, from Agilent Technologies). Yeast strains are listed in S2 Table, and were 7 
constructed by meiotic crossing and DNA transformation [54][55]. The yeast media and 8 
genetic techniques were described previously [56]. yCNOD226-1a was obtained from 9 
yCNOD223-2a by switching the KAN-MX to the NAT-MX marker under the control of the 10 
MF(ALPHA)2/YGL089C promoter (alphaNAT-MX4), which allowed selection of MATα 11 
haploid cells [33]. OGT9-6a is an offspring of yCNOD226-1a crossed with BY4741. OGT8-12 
11a is an offspring of BY4742 crossed with Y1196. Strains OGT9-6a and OGT8-11a were 13 
plated on rich media and UV irradiated (5W/m2 during 5 second), resulting in 50% survival. 14 
LH514D and LH11D are suppressor clones of the growth defect selected from UV-irradiated 15 
OGT9-6a grown at 25°C. AH29R is a suppressor clone of the growth defect selected from 16 
UV-irradiated OGT8-11a grown at 25°C. Genetic interaction mapping (GIM) analysis of the 17 
RPA49 deletion mutant was performed as described previously [33]. Microarray data were 18 
normalized using MATLAB (MathWorks, Inc., Natick, MA) as previously described [29]. 19 
OGT15-7b is an offspring of LH514D with BY4741, followed by homologous recombination 20 
using PCR-amplified fragments generated with oligos 1716 and 1717 and pCR4-HIS3 as 21 
template. yTD16-1a was first transformed with plasmid pCJPF4-GAL49-1. Then, RPA135 22 
was tagged by homologous recombination using PCR-amplified fragments generated with 23 
oligos 835 and 836 and genomic DNA of strain RPA135-TAP or yTD6-6c, generating yTD27-24 
1 and yTD28-1a, respectively. Strain yTD25-1a bears a C-terminal deletion of RPA49 25 
generated by homologous recombination using PCR-amplified fragments generated with 1 
oligos 208 and 1515 and pFA6-KAN-MX6 as template. yTD11-1a was derived from strain 2 
yTD25-1a after switching to HPH-MX by homologous recombination using pUC19-HPH cut 3 
by BamHI. C-terminal deletion of RPA49 in yTD29-1a and yTD30-1a were generated by 4 
homologous recombination using PCR-amplified fragments generated with oligos 649 and 5 
650 and yTD11-1 genomic DNA as template, transformed into yTD27-1 and yTD28-1a, 6 
respectively. Genomic allelic insertion of RPA12-S6L in yTD31-1a and yTD23-1a was 7 
performed by homologous recombination using PCR-amplified fragments generated with 8 
oligos 1556 and 1557 and pRS316-A12-S6L-KAN as template, transformed into yTD27-1 9 
and yTD29-1a, respectively. 10 
TGT135-3b was obtained after sporulation of y27138 transformed by pNOY80. TGT135-3b 11 
and OGT15-9d were mated to generate TGT12. yTD2-3b and yTD2-3d are offspring of 12 
TGT12 transformed with pGL135_33. yTD6-6c and yTD6-6b were generated by homologous 13 
recombination using pTD2_6c_135TAP cut with XhoI-NsiI, transformed into yTD2-3b and 14 
yTD2-3d, respectively. yTD48-1a was generated by deletion of the Rpa190 DNA-mimicking 15 
loop using homologous recombination with PCR-amplified fragments generated using oligos 16 
1189 and 1194 and genomic DNA of strain SCOC2260 as template, transformed into 17 
BY4741.  18 
yTD51-2c, yTD51-8a, and yTD51-5a are offspring of yTD48-1a mated with yTD37-3a. 19 
yTD36-2b is an offspring of yCN224-1a mated with yTD40-1a. yTD37-3d and yTD37-7d are 20 
offspring of yCN224-1a mated with yTD41-1a. yTD38-3d is an offspring of yCN225-1a 21 
mated with yTD40-1a and yTD39-8a is an offspring of yCN225-1a mated with yTD41-1a. 22 
Strain yTD53-1a was constructed by homologous recombination using a PCR-amplified 23 
fragment generated with oligos 1634 and 1635 and pFA6a-KanMX6-GAL::3HA as template. 24 
OGT30-1a and OGT30-3a are offspring of yTD53-1a mated with yTD6-6b. yTD40-1a and 1 
yTD41-1a were generated by homologous recombination using PCR-amplified fragments 2 
generated with oligos 700 and 1679 and pFA6a-HA-KlURA3 as template, transformed into 3 
OGT30-3a and OGT30-1a respectively, switching RPA135-TAP-tag to untagged RPA135. 4 
Strain yMKS8-1a was constructed by homologous recombination using a PCR-amplified 5 
fragment generated with oligos 1711 and 1713 and pFA6a-KanMX6-GAL::3HA as template, 6 
transformed into strain yCD2-2a. yMKS9-9d is offspring of yMKS8-1a mated with yTD6-6c. 7 
Mapping extragenic suppressors allele by genetic linkage 8 
Extragenic suppressors allele SGR were mapped using GIM methods, in which a strain is 9 
crossed with the entire pool of haploid deletion strains [57]. Here, deletions are used to 10 
evaluate linkage to SGR locus. Due to the genetic suppression, Individual deletions 11 
genetically linked to SGR are counter-selected in rpa49∆ background. Genetic mapping of 12 
SGR locus is based on strong genetic linkage of counter-selected deletion alleles (see S1 Fig), 13 
evaluated using micro-array of deletion bar-code (ArrayExpress accession E-MTAB-7831) 14 
[58]. 15 
 16 
In vivo labelling and RNA extraction and analysis 17 
Metabolic labelling of pre-rRNA was performed as previously described [59] with the 18 
following modifications. Strains were pre-grown in synthetic glucose-containing medium 19 
lacking adenine at 30°C to an OD600 of 0.8 at. One-milliliter cultures were labeled with 50 20 
µCi [8-3H] adenine (NET06300 PerkinElmer) for 2 min. Cells were collected by 21 
centrifugation and the pellets were frozen in liquid nitrogen. RNA was then extracted as 22 
previously described [60] and precipitated with ethanol. For high molecular weight RNA 23 
analysis, 20% of the RNA was glyoxal denatured and resolved on a 1.2% agarose gel. Low 24 
molecular weight RNAs were resolved on 8% polyacrylamide/8.3 M urea gels.  25 
Miller spreads experiments and analysis 1 
Chromatin spreading was mainly performed as described previously with minor modifications 2 
[61]. Carbon-coated grids were rendered hydrophilic by glow discharge instead of ethanol 3 
treatment. Negatively stained chromatin was obtained by short incubation with heavy metal 4 
followed by quick drying of the sample. Images were obtained using a JEOL JEM-1400 HC 5 
electron microscope (40 to 120 kV) with an Orius camera (11Mpixels). The position of the 6 
RNA polymerase I molecules and the rDNA fiber were determined by visual inspection of 7 
micrographs using Image J (http://rsb.info.nih.gov/ij/). Digital images were processed by 8 
software programs Image J and Adobe Photoshop® (v. CS6). 9 
 10 
In vitro promoter-dependent and tailed template transcription assays 11 
In vitro promoter-dependent transcription reactions were performed as previously described 12 
[23,62] with some modifications. Briefly, 1.5 ml reaction tubes (Sarstedt safety seal) were 13 
placed on ice. Template (0.5–1 µl; 50–100 ng DNA) was added, corresponding to a final 14 
concentration of 5–10 nM per transcription reaction (25-µl reaction volume). Core factor (1–2 15 
µl; 0.5 to 1 pmol/µl; final concentration 20–40 nM) and 1–3 µl Pol I (final concentration 4–12 16 
nM) were added to each tube. Then, 20 mM HEPES/KOH pH 7.8 was added to a final 17 
volume of 12.5 µl. Transcription was started by adding 12.5 µl 2X transcription buffer. The 18 
samples were incubated at 24°C for 30 min at 400 rpm in a thermomixer.  19 
25 nM of tailed templates were used in a total volume of 25 µl. The transcription was 20 
performed as described in promoter-dependent transcription reactions: Tailed templates are 21 
PCR-amplified fragments generated with oligos 1834 and 1835 and “pUC19tail_g-22 
_601_elongated” as PCR-template, treated with Nb.BsmI (NEB) to generate a nick. Nicked 23 
site allows non-specific initiation of Pol I without the addition of initiation factors. 24 
 25 
Transcription was stopped by adding 200 µl Proteinase K buffer (0.5 mg/ml Proteinase K in 1 
0.3 M NaCl, 10 mM Tris/HCl pH 7.5, 5 mM EDTA, and 0.6% SDS) to the supernatant. The 2 
samples were incubated at 30°C for 15 min at 400 rpm in a thermomixer. Ethanol (700 µl) 3 
p.a. was added and the tubes mixed. Nucleic acids were precipitated at -20°C overnight or for 4 
30 min at -80°C. The samples were centrifuged for 10 min at 12,000g and the supernatant 5 
removed. The precipitate was washed with 0.15 ml 70% ethanol. After centrifugation, the 6 
supernatant was removed and the pellets dried at 95°C for 2 min. RNA in the pellet was 7 
dissolved in 12 µl 80% formamide, 0.1 M TRIS-Borate-EDTA (TBE), 0.02% bromophenol 8 
blue, and 0.02% xylene cyanol. Samples were heated for 2 min with vigorous shaking at 95°C 9 
and briefly centrifuged. After loading on a 6% polyacrylamide gel containing 7M urea and 1X 10 
TBE, RNAs were separated by applying 25 watts for 30–40 min. The gel was rinsed in water 11 
for 10 min and dried for 30 min at 80°C using a vacuum dryer. Radiolabelled transcripts were 12 
visualised using a PhosphoImager.  13 
 14 
RNA extractions and Northern Hybridizations. 15 
RNA extractions and Northern hybridizations were performed as previously described [60]. 16 
For high molecular weight RNA analysis, 3µg of total RNA were glyoxal denatured, resolved 17 
on a 1.2% agarose gel and transferred to a nylon membrane. The sequences of 18 
oligonucleotides used to detect the RNA species: 35S rRNA, 25S rRNA, 20S rRNA, 18S 19 
rRNA, 27S rRNA, PGK1 mRNA and SCR1 ncRNA are respectively 774, 1829, 1833, 892, 20 
1830, 1831 and 1832 are reported in S4 Table. 21 
Chromatin immunoprecipitation (ChIP). ChIPs were performed essentially as described 22 
previously [63]. At least three independent cultures of each yeast strain were grown to 23 
exponential phase OD600 = 0.4-0.8 in YPD (yeast extract-peptone-glucose) at 30°C, and cross-24 
linked for 10 min at RT by the addition of formaldehyde (F1635, SIGMA) to a final 25 
concentration of 1.2%. Adding glycine quenched the cross-linking reaction. Cells were 1 
broken in lysis buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% Triton X-2 
100, 0.1% deoxycholate Na, 0.1% SDS, 1 mM AEBSF [Euromedex] and cOmplete EDTA-3 
free [Roche]) with glass beads (diameter, 0.425 to 0.6 mm; SIGMA) in a Precellys 24 4 
homogenizer (bertin technologies) for 3 min, 6000 rpm at 4°C. Extracted chromatin was 5 
sonicated to obtain 300-500 bp DNA fragments. 100 μg of sonicated chromatin (protein 6 
content measured using BCA Protein Assay kit, ref# 23225, Thermo Scientific) was 7 
immunoprecipitated for 4h at 21°C on Pan mouse Dynabeads (Invitrogen, 200 µl). 8 
Immunoprecipitated DNA was purified and quantified by real-time qPCR using iTaq 9 
universal SYBR®Green Supermix (Bio-Rad) and the ViiA7 AB Applied Biosystems (Life 10 
Technologies). Primer pairs used for amplification are listed in S4 table. Signals were 11 
analysed with Quant Studio Real Time PCR Software v1.1 and are expressed as percentage of 12 
input DNA. Bars on the graph show the median of values normalised to wild-type value. 13 
Error bars correspond to standard deviations of at least three independent cultures for each 14 
strain. 15 
Pulse-field gel electrophoresis (PFGE). PFGE is a technique that resolves chromosome-16 
sized DNA molecules in an agarose gel. Over-night YPD cultures at 30°C were harvested in 17 
0.1% azide Na and kept on ice. Cells were washed twice in cold 0.05 M EDTA [pH 8.0]. 18 
~2.108 cells were resuspended in 1ml of freshly prepared NZ buffer (Citrate Phosphate buffer 19 
33 mM, ETDA 0.05 M [pH 8.0], Sorbitol 1.2 M). Cells were pellets (8000 rpm, 1 min, 4°C) 20 
and resuspended in 500 µL of Zymolyase buffer (NZ buffer with 20T zymolyase) and 500 µL 21 
LMP 2% (SeaKem LE agarose, Lonza, ref# 50001). Homogenized pellets were poured into 22 
the plug molds (~100 µl/plug) and incubated for 30 min in humid chamber at 37°C then 10 23 
min at 4°C. Solidified plugs were transferred in 14 ml tubes with round bottom and incubate 24 
with 400 µl/plug of PK buffer (EDTA 0.125 M [pH 9.5], Sarkosyl 1%, PK 1 mg/ml (Roche, 25 
ref# 03115801001) and incubated 1-2 hours at 37°C with gentle agitation. PK buffer was 1 
changed and plugs were incubated O/N with gentle agitation. De-proteinated plugs were 2 
washed with 10 ml TE followed by washing with 10 ml TE + 1 mM AEBSF (Euromedex) for 3 
2 hours. AEBSF was washed out twice with 10 ml of 0.05 M EDTA [pH 8.0] for 30 minutes. 4 
Plugs were stored at 4°C till usage in TE or 0.05 M EDTA [pH 8.0]. Plugs were loaded on 5 
0.8% agarose gel in 1×TAE buffer (Certified Megabase agarose, Bio-Rad, ref# 161-3109) and 6 
run in 1×TAE buffer for 50h in CHEF-DRIII System with chiller unit (Bio-Rad) with 7 
following parameters: 3V/cm, initial S/time 250 sec, final S/time 900 sec, angle 120. Gel was 8 
stained with ethidium bromide (10 mg/ml in water). Gel was processed for Southern blotting: 9 
DNA was transferred on nylon membrane by passive transfer in 10×SSC buffer (Amersham 10 
Hybond XL, GE Healthcare). Membranes were UV-cross-linked and hybridized overnight 11 
with 32P-labeled single-stranded DNA probes at 42 °C. Blots were washed twice with 2×SSC 12 
and 1% SDS for 20 min and once with 0.5×SSC and 1% SDS for 20 min at 37 °C. rDNA 13 
locus (chromosome XII) was detected with 18S specific probe 14 
(CATGGCTTAATCTTTGAGAC). This protocol was kindly provided by B. Pardo (IGH, 15 
Montpellier, France), and is extensively described in [64].  16 
 17 
Transcriptional run-on analysis 18 
TRO was performed as previously described [39,43]. Slot blots were loaded with single-19 
stranded 80-mers DNA oligonucleotides: 1855 (NTS2), 1857 (5’ETS), 1859 (18S.2), 1860 20 
(25S.1), 1861 (3’ETS), 1862 (NTS1), 1863 (5S US) and 1864 (5S DS). 21 
 22 
 23 
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Figure legends 1 
Figure 1. Alleles of RPA190 and RPA135 suppress the growth defect of the rpa49∆ 2 
mutant at various levels. (A) The SGR1 mutant restores growth of the rpa49∆ mutant. Ten-3 
fold serial dilutions of wild-type (WT), rpa49∆ single mutant, SGR1 single mutant, and 4 
SGR1/rpa49∆ double mutant strains were spotted on rich media to assess growth at 30 and 5 
25°C for three days. (B) Ten-fold dilutions of WT and rpa49∆ compared to rpa49∆ carrying 6 
various plasmids: pGL190_3 (RPA190-E1274K), pGL190_11 (RPA190-C1493R), 7 
pGL190_23 (RPA190-L1262P), pGL135_6prim (RPA135-R379G), pGL135_54 (RPA135-8 
Y252H), or pGL135_33 (RPA135-F301S). Growth was evaluated after three days at 25°C. 9 
The strains and plasmids used are listed in S2-S3 Tables, respectively. 10 
Figure 2. Mapping of the modified residues in Rpa190, Rpa135 on the structure of Pol I 11 
and isolation of Rpa12 alleles. (A) Two different views of the initially transcribing complex 12 
model and its 14 different subunits (PDB 5W66[15]). (B) Most mutated suppressor residues 13 
are clustered at the interface between the jaw (Rpa190, blue) and lobe (Rpa135, salmon) 14 
modules of Pol I. Note that residues 46- 51 in Rpa12 (yellow) are part of this interface. (C) 15 
Zoom views of the areas containing the modified residues (Rpa190-N863, -S1259, -L1262, -16 
E1274, -C1493; Rpa135-Y252, D299, S300, F301, R305; and Rpa12-S6, T49) shown in 17 
panel B. The figure was prepared with Pymol using the crystal structure of Pol I PDB 4C3I 18 
[4]). (D) Ten-fold dilutions of the rpa49∆ mutant carrying various plasmids: an empty 19 
pRS316 plasmid (-) YCp50-26 bearing RPA49 (RPA49), pRS316-A12-S6L (RPA12-S6L), or 20 
pRS316-A12-T49A (RPA12-T49A). Growth was evaluated after three days at 25°C or two 21 
days at 30°C. 22 
Figure 3. RPA135-F301S and RPA12-S6L alleles restore growth and rRNA synthesis, 23 
and modulate Pol I occupancy of rDNA genes in the absence of Rpa49Ct. (A) Doubling 24 
times of WT, rpa49∆Ct, RPA135-F301S, rpa49∆Ct/RPA135-F301S double mutant, RPA12-1 
S6L, and the rpa49∆Ct/RPA12-S6L double mutant in a low rDNA copy number background 2 
(see S2 Table). (B) In vivo labelling of newly synthesized RNAs. WT (lane 1), rpa49∆Ct 3 
(lanes 2-4), RPA135-F301S (lane 5), the rpa49∆Ct/RPA135-F301S double mutant (lane 6), 4 
RPA12-S6L (Lane 7), the rpa49∆Ct/RPA12-S6L double mutant (lane 8) were grown to an 5 
OD600 of 0.8. Cells were then pulse-labeled with [8-
3H] adenine for 2 min. Samples were 6 
collected, and total RNA extracted and separated by gel electrophoresis. (C) Representative 7 
Miller spreads of WT, rpa49∆Ct, RPA135-F301S, rpa49∆Ct/RPA135-F301S, and 8 
rpa49∆Ct/RPA12-S6L double mutant. Panels on the right of each micrograph show 9 
interpretive tracing of the genes. Polymerases that appear on the gene are shown on the 10 
tracing by black dots. The number of polymerases counted on the genes is indicated below. N 11 
represents the number of individual spread genes used for quantification (see Materials and 12 
Methods). Scale bar = 200 nm. (D) ChIP analysis of Pol I occupancy at rDNA. Strains 13 
bearing WT Pol I, expressing Rpa49 lacking its C-terminal part (rpa49ΔCt), bearing 14 
suppressor mutation (RPA135-F301S) or double mutant, were subjected to ChIP experiments 15 
using TAP tagged Rpa135, as described in Materials and Methods. Experiments were 16 
reproduced three times, representative Pol I occupancy relative to WT level are shown. 17 
Position of qPCR amplicons are depicted on rDNA unit. ** Marks significantly different 18 
values (p-values > 0.01) in student’s test of rpa49∆Ct with WT, RPA135-F301S and double 19 
rpa49∆Ct RPA135-F301S.  20 
 21 
Figure 4. Rpa14, Rpa34, and the DNA mimicking loop of Rpa190 are not required for 22 
suppression. Deletion of the DNA mimicking loop of Rpa190 (A) or RPA34 (B) does not 23 
modulate the suppression activity of RPA135-F301S. (C) RPA135-F301S suppresses the 24 
synthetic lethality between rpa14∆ and rpa49∆. Ten-fold serial dilutions were performed and 1 
growth evaluated after three days at 25°C. 2 
Figure 5. RPA12 alleles can modulate the rpa49∆-associated growth defect. (A) Growth of 3 
the double mutants: rpa49∆ rpa12∆Ct, or rpa49∆ combined with full depletion of rpa12. 4 
Depletion of Rpa12 was achieved using a pGAL-RPA12 construct on glucose containing 5 
medium (strain OGT30-1c). Ten-fold serial dilutions of OGT30-1c bearing pRS316-A12 6 
(WT), pRS316-A12-DCt expressing Rpa12 bearing a C-terminal deletion of residues 65-125 7 
(rpa12∆Ct), or an empty plasmid pRS316 (-rpa12) were seeded onto media. The growth of 8 
rpa49∆ combined with RPA12 depletion was tested using strain OGT30-3c bearing pRS316-9 
A12 (rpa49∆), pRS316-A12-DCt (rpa12∆Ct rpa49∆), or an empty plasmid pRS316 (-rpa12 10 
rpa49∆). Growth was assessed after four days at 25°C or 30°C. (B) The C terminus of Rpa12 11 
is not required for suppression. Ten-fold serial dilutions of OGT30-1c (RPA49-WT), bearing 12 
pRS316-A12 (WT) or pRS316-A12-DCter (rpa12∆Ct), and OGT30-3c (rpa49∆), bearing 13 
pRS316-A12 (WT), pRS316-A12-DCter (rpa12∆Ct), pRS316-A12-S6L (RPA12-S6L), or 14 
pTD10 (RPA12-S6L-∆Ct) were seeded onto media. Growth was assessed after four days at 15 
25°C. (C) Suppression activity of RPA135-F301S is abolished in the absence of Rpa12. 16 
RPA12, under a regulatable promoter (pGAL) was either expressed (+RPA12; left panel) on 17 
galactose containing medium or repressed (-RPA12; right panel) on glucose containing 18 
medium. Ten-fold serial dilutions of RPA49, rpa49∆, RPA49, RPA135-F301S, or rpa49∆ 19 
RPA135-F301S were grown at 25°C. Depletion of RPA12 abolishes the suppression activity 20 
of RPA135-F301S (compare the left to the middle and right panels). Extended incubation 21 
(right panel, 10 days) was used to detect growth of the double mutant -RPA12 rpa49∆ on 22 
plates. 23 
Figure 6. In vitro transcription assays of WT Pol I and Pol I mutants. WT, Pol A* (lacking 24 
Rpa34 and Rpa49), Pol I bearing Rpa135-F301S, and Pol A* bearing Rpa135-F301S were 25 
affinity-purified and 5 nM of each enzyme was used in either promoter dependent (A) or 1 
tailed template assay (B). Promoter-dependent assays were performed in the presence of 70 2 
nM Rrn3 and 20 nM CF. Radiolabelled transcripts were separated on a denaturing 3 
polyacrylamide/urea gel and detected using a PhosphorImager. Note that upper radiolabeled 4 
bands in the experiment analyzing promoter-dependent transcription are due to nonspecific 5 
background labelling. Experiments were reproduced at least three times, with different Pol I 6 
concentration; representative experiments is shown. 7 
 8 
Figure 7. RPA135-F301S led to over-production of rRNA in vivo. (A) WT, RPA135-F301S, rrp6∆ 9 
and RPA135-F301S∆ rrp6∆ strains were grown to mid-log phase in glucose containing media. Cell 10 
samples were collected and total RNAs were extracted, separated by gel electrophoresis and 11 
transferred to a nylon membrane. The accumulation of the different (pre-) rRNAs was then analyzed 12 
by northern blot using different probes (see Materials and Methods). (B) In vivo labelling of newly-13 
synthesized RNAs. WT, RPA135-F301S, rrp6∆ and RPA135-F301S∆ rrp6∆ strains were grown to an 14 
OD600 of 0.8. Cells were then pulse-labeled with [8-3H] adenine for 40 seconds. Samples were 15 
collected, and total RNA extracted and separated by gel electrophoresis. Newly-synthetized RNA are 16 
revealed by autoradiography, loading control was performed by northern blot (PGK1 mRNA probe – 17 
1831) on the same membrane. (C) High-resolution transcriptional run-on (TRO) analysis of WT, 18 
RPA135-F301S, rrp6∆ and RPA135-F301S∆ rrp6∆ strains. Nascent transcripts were labelled, and 19 
revealed using antisens oligonucleotides immobilized on slot-blot as described in Materials and 20 
Methods. Each experiment was performed twice; a representative example is shown in the lower left 21 
panel. NTS2, Pol I (mean of 5’ETS, 18S.2, 25S.1, 3’ ETS) are quantified relative to 5S signal in the 22 
lower right panel. Yeast rDNA unit is represented in the upper panel, with the position of the 23 
corresponding antisense oligonucleotides used. 24 
 25 
Figure 8. Schematic representation of Pol I. (A) Free monomeric Pol I with mobile 26 
Rpa49Ct and linker. (B) Initially transcribing complex (ITC) upon insertion of melted DNA 27 
in the presence of Rpa49 (purple). Rpa49Ct interacts with upstream DNA and the Rpa49-1 
linker is folded, closing the cleft (black anchor). Movements of Rpa12 and the jaw with 2 
respect to the lobe are indicated with arrows. (C) Pol I lacking Rpa49 is likely defective in 3 
stabilizing the closed conformation in the DNA-binding cleft, resulting in a looser gripping of 4 
DNA inside the cleft (red asterisks). (D) Suppressor mutations (green) facilitate movement of 5 
the jaw/lobe interface and gripping of the DNA by the Pol I enzyme (red arrow), in the 6 
absence of Rpa49. (E) Combination of the presence of Rpa49 and a suppressor mutation 7 
(green dot) results in a super-active Pol I compared to the WT enzyme. 8 
 9 
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Supporting information Legends 1 
 2 
S1 Fig: Genetic interaction mapping (GIM) to identify suppressor mutations in SGR1 3 
and SGR2. (A) Schematic representation of GIM interaction assay. Enrichment ratios 4 
between control and SGR are used as read-out to map genetic interactions. (B) Relative 5 
enrichment of each barcode (black cross) along chromosome (in red) is used to map genetic 6 
linkage. Green curve represents mean in a sliding windows of 20 barcodes. Local maximum 7 
in such curve was used to identify locus of interest: RPA49 as positive control (upper panel, 8 
chr 14); RPA135 in SGR1 (middle panel, chr 16) ; RPA190 in SGR2 (lower panel, chr 15). 9 
 10 
S2 Fig: Mapping of the mutated residues in Rpa135. (A) Structural domains of Rpa135 are 11 
depicted [4,5], including the lobe domain in which mutations are clustered. (B) Sequences 12 
alignment of positions 251-310 of Rpa135 from S. cerevisiae (NP_015335.1), compared with 13 
S. pombe (NP_595819.2), H. sapiens (NP_061887.2) , M. musculus (NP_033112.2 ), D. rerio 14 
(NP_956812.2), D. melanogaster (NP_476708.1) and C. elegans (NP_492476.1 ). Color code 15 
from light to dark blue indicates residue conservations. Mutated residues at position 252 (Y to 16 
H), 299 (D to G), 300 (S to F), 301 (F to S or L) and 305 (R to L) are depicted in red. 17 
 18 
S3 Fig: Analysis of the rDNA size by pulse field gel electrophoresis. Chromosomes from 19 
indicated strains (same as in Fig. 3D, two clones) were separated on the agarose gel and 20 
analysed by Southern blot using rDNA-specific probe. 21 
 22 
S4 Fig: Promoter dependent in vitro transcription assays of Pol A* (lacking Rpa34 and 23 
Rpa49) and Pol A* bearing Rpa135-F301S are complemented with recombinant A34.5/A49 24 
heterodimer. Promoter-dependent assays were performed as in fig. 6, with recombinant 25 
A49/A34.5 protein, described in [23]. 26 
 1 
S5 Fig: Ten-fold serial dilutions of WT, RPA135-F301S, rrp6∆ and RPA135-F301S - 2 
rrp6∆ grown at 25°C for 3 days. 3 
 4 
S6 Fig: Subunit Rpa12 support in vitro Pol I transcription initiation and non-specific 5 
transcription. Tailed template and promoter-dependent assays were performed as in fig. 6, as 6 
previously described [23]. Tailed template assays (lane 1-3) and promoter specific 7 
transcription (lane 4-6) were performed using 4 WT Pol I or 4 and 12 nM of Pol I lacking 8 
Rpa12. Quantification relative to WT activity is shown for each lane. 9 
 10 
S1 Table: List of 24 individual suppressor mutations of the growth defect of rpa49∆ strain in 11 
the Rpa190, Rpa135, and Rpa12 subunits.  12 
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S2 Table: Yeast strains used in this study. 14 
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S3 Table: Plasmids used in this study. 16 
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S4 Table: Oligonucleotides used in this study. 18 
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S1 Movie: Conformational changes in Pol I upon initiation. The movie starts with the closed 20 
cleft conformation (PDB 5W66 [15]), in which melted DNA occupies the cleft and then 21 
changes to the intermediate cleft conformation observed in monomeric Pol I (PDB 5M3M 22 
[35]). Relevant structural regions have been variously colored and labeled, and residues 23 
mutated in this report are shown in red. 24 
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Supplementary Figure 1 
AB
Mapping of the mutated residues in Rpa135. (A) Structural domains of Rpa135 are depicted [4,5], including 
the lobe domain in which mutations are clustered. (B) Sequences alignment of positions 251-310 of Rpa135 
from S. cerevisiae (NP_015335.1), compared with S. pombe (NP_595819.2), H. sapiens (NP_061887.2) , M. 
musculus (NP_033112.2 ), D. rerio (NP_956812.2), D. melanogaster (NP_476708.1) and C. elegans 
(NP_492476.1 ). Color code from light to dark blue indicates residu conservations. Mutated residues at 
position 252 (Y to H), 299 (D to G), 300 (S to F), 301 (F to S or L) and 305 (R to L) are depicted in red.
1 1203210 39942 470 553 697 800 911 1069
Hybrid
bindingWall
Hybrid
bindingForkLobeProtrusion
L         
Suppressors    H                                                                     GFS   L     
S. cerevisiae SYSHYGIQIRSVRPDQTSQTNVLHYLNDGQVTFRFSWRKNEYLVPVVMILKALCHTSDREIFDGIIGNDVKDSFLTDRLELLL
S. pombe  SYSQYGLSIRCVRPDQSSLTNTLHYLNNGVTMFRFHWRKNEYLIPSMMILKALLETSDKEIFEGIVGKDLGNTFLTDRVELML
H. sapiens  GYTQYGVSMHCVREEHSAVNMNLHYLENGTVMLNFIYRKELFFLPLGFALKALVSFSDYQIFQELIKGKEDDSFLRNSVSQML
M. musculus  GYTQFGVSMRCVREEHSAVNMNLHYVENGTVMLNFIYRKELFFLPLGFALKALVSFSDYQIFQELIKGKEEDSFFRNSVSQML
D. rerio  GYTQYAISMRCVKEEHTAINMNLHYLDNGTVMVNFIYRKELFFLPLGFALKALVDYSDYQIYQELIKGREDNSFYKSCVSEML
D. melanogaster NFSDLGMLVQTVREDESSLSNVVHYLNNGTAKFMFSHVKRLSYVPVCLILKCLMDYTDEEIYNRLVQGYESDQYYV-SCVQAM
C. elegans  LFSEFGVMMRSVKENHTAVMMTLHYLDTGTMQLALQFRREIFYVPLMYIVKALTDKNDAVISAGFKRGRNQDQFYSSCILNML
                                                                                             
251
Rpa135
310
Supplementary Figure 2 
 1
90
 rD
N
A 
co
pi
es
fob1∆
 25 rDNA copies
R
PA
49
R
PA
13
5-
F3
01
S
R
PA
13
5-
F3
01
S
rp
a4
9∆
C
t
rp
a4
9∆
C
t
R
PA
49
rr
p6
∆
rr
p6
∆
R
PA
13
5-
F3
01
S
R
PA
13
5-
F3
01
S
chr XII
chr XII
EtBr staining
Southern blot
Supplementary Figure 3 
Analysis of the rDNA size by pulse eld gel electrophoresis. 
Chromosomes from indicated strains (same as in Fig. 3D, two clones) were separated on the agarose gel 
and analysed by Southern blot using rDNA-specic probe.
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Promoter dependent in vitro transcription assays of Pol A* (lacking Rpa34 and 
Rpa49) and Pol A* bearing Rpa135-F301S are complemented with recombinant 
A34.5/A49 heterodimer. Promoter-dependent assays were performed as in fig. 6, 
with recombinant A49/A34.5 protein, described in [23].
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Supplementary Figure 5 
Supplementary Figure 6
Subunit Rpa12 support in vitro Pol I transcription initiation and non-specific transcription. 
Tailed template and promoter-dependent assays were performed as in fig. 6, as 
previously described [23]. Tailed template assays (lane 1-3) and promoter specific 
transcription (lane 4-6) were performed using 4 WT Pol I or 4 and 12 nM of Pol I lacking 
Rpa12. Quantification relative to WT activity is shown for each lane.
 
Supplementary tables 
Sub. Allele Strength Hotspot Location Mutant effect 
Rpa190 N863T Weak Funnel Funnel/ Rpa12-linker Destabilization of 
Funnel/Rpa12 
Rpa190 S1259L Medium Jaw Jaw/Shelf hinge Hinge conformation 
Rpa190 L1262P Weak Jaw Jaw/Shelf hinge Hinge conformation 
Rpa190 E1274K Medium Jaw Jaw/ Rpa12-linker interface Destabilization of Jaw/Rpa12 
Rpa190 C1493R Medium Jaw Jaw/ Rpa12-linker interface Destabilization of Jaw/Rpa12 
Rpa135 Y252H Strong Lobe Jaw/Lobe interface Destabilization of Jaw/Lobe 
Rpa135 D299G Medium Lobe Jaw/Lobe interface Destabilization of Jaw/Lobe 
Rpa135 S300F Medium Lobe Jaw/Lobe interface Destabilization of Jaw/Lobe 
Rpa135 F301S Strong Lobe Jaw/Lobe interface Destabilization of Jaw/Lobe 
Rpa135 F301L Strong Lobe Jaw/Lobe interface Destabilization of Jaw/Lobe 
Rpa135 SGR3 
R305L 
Medium Lobe Jaw/Lobe interface Destabilization of Jaw/Lobe 
Rpa12 S6L Medium N-terminal Jaw/ Rpa12-linker interface Destabilization of Jaw/Rpa12 
Rpa12 T49A Medium Linker Jaw/ Rpa12-linker interface Destabilization of Jaw/Rpa12 
Rpa190 L608S Medium    
Rpa190 E611K Medium    
Rpa190 S936A Weak    
Rpa190 SGR2 
A1557V 
Weak    
Rpa135 D157G Medium    
Rpa135 D157N Medium    
Rpa135 SGR1 
I218/ 
R379K 
Medium    
Rpa135 R379G Strong    
Rpa135 G580D Medium    
Rpa135 C584Y Weak    
Rpa135 I913V Medium    
 
Supplementary table 1. List of 24 individual suppressor mutations of the growth defect of 
rpa49∆ strain in the Rpa190, Rpa135, and Rpa12 subunits (Sub.). The suppressors were 
classified according to growth rate when combined with rpa49∆ mutant: weak, medium, or 
strong. SGR1, 2, and 3 depict alleles originally isolated after UV mutagenesis (see text). 
Thirteen of the 24 mutants, affecting 12 different positions, were found in a specific hot-spot 
shown in Figure 4. Residues substitution in the 3D structure were performed in silico, and 
putative mutant effects were deduced from the obtained structure. 
 
  
Supplementary table 2: Yeast strains used in this study 
 
Referred to as strain Genotype source 
WT in figures 1,4 
and 7  
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 Euroscarf 
 BY4742 MATalpha his3∆1 leu2∆0 lys2∆0 ura3∆0 Euroscarf 
 y1196 MATa his3∆1 leu2∆0 lys2∆0 ura3∆0 rpa49∆::KANMX4 Euroscarf 
 y27138 MATa/alpha his3∆1/his3∆1 leu2∆0/leu2∆0 ura3∆0/ura3∆0 
lys2∆0/LYS2 MET15/met15∆0 rpa135∆::KANMX4/RPA135 
Euroscarf 
 TGT135-3b MATa his3∆11 leu2∆0 ura3∆0 lys2∆0 rpa135∆::KANMX4 
+pNOY80 
Euroscarf 
 TGT12 MATa/alpha his3∆1/his3∆1 leu2∆0/leu2∆0 ura3∆0/ura3∆0 
lys2∆0/lys2∆0 rpa135∆::KANMX4/RPA135 
rpa49∆::HPHMX4/RPA49 
Euroscarf 
rpa49∆ in figure 1, 
with the plasmids 
indicated in the 
legend 
OGT9-6a MATalpha his3∆1 leu2∆0 met15∆0 ura3∆0 
rpa49∆::alphaNATMX6 
This study 
rpa49∆ in figure 4A, 
with the plasmids 
indicated in the 
legend 
OGT8-11a MATa his3∆1 leu2∆0 lys∆0 ura3∆0 rpa49∆::KANMX6 This study 
SGR1 in figure 1 OGT15-7b MATa his3∆1 leu2∆0 lys∆0 ura3∆0 HIS3::RPA135(I218T, R379K) This study 
 
SGR1 rpa49∆ in 
figure 1 
LH514D  MATalpha his3∆1 leu2∆0 met15∆0 ura3∆0 rpa49∆-alphaNAT 
RPA135(I218T, R379K) 
This study 
 
 AH29R MATa his3∆1 leu2∆0 lys∆0 ura3∆ rpa49∆- kanmx4 RPA190-
1557V 
This study 
 
SGR2 AC5-3b MATalpha his3∆1 leu2∆0 lys∆0 ura3∆ rpa49∆-alphaNAT 
RPA190-1557V 
This study 
 
SGR3 LH11D MATalpha his3∆1 leu2∆0 met15∆0 ura3∆0 rpa49∆-alphaNAT 
RPA135-R305L 
This study 
 
 RPA135-TAP MATalpha his3∆1 leu2∆0 met15∆0 ura3∆0 RPA135-
TAP::HIS3MX6 
202233825 
[54] 
 yTD16-1a MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 
fob1∆::NAT-MX, rDNA copy no. ~25 
This study 
 
 yTD6-6c MATa ura3∆0 his3-Δ1 leu2-Δ0 lys2-Δ0 RPA135-F301S-TAP-HIS3 This study 
rpa49∆ in figures 2, 
4A, 5  
OGT15-9d MATalpha his3∆1 leu2∆0 lys∆0 ura3∆0 rpa49∆::HPHMX This study 
 
WT in figures 3 yTD27-1a MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu-3,112 can1-100 
fob1∆::NAT-MX RPA135-TAP-HIS3, rDNA copy number ~25 
+ pCJF4-LEU-GAL49 
This study 
 
RPA135-F301S in 
figure 3 
yTD28-1a MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu-3,112 can1-100 
fob1∆::NAT-MX RPA135-F301S-TAP-HIS3, rDNA copy number 
~25, + pCJF4-LEU-GAL49 
This study 
 
 yTD25-1a MATa his3∆1 leu2∆0 met15∆0 ura3∆0 rpa49∆C(186-416)::KAN-
MX4 
This study 
 
 yTD11-1a MATa his3∆1 leu2∆0 met15∆0 ura3∆0 rpa49∆C(186-416)::HPH-
MX4  
This study 
 
rpa49∆Ct in figure 3 yTD29-1a MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu-3,112 can1-100 
fob1∆::NAT-MX RPA135 -TAP-HIS3 rpa49∆C(186-416)::HPH, 
rDNA copy number ~25, 
 + pCJF4-LEU-GAL49 
This study 
 
rpa49∆Ct  
RPA135-F301S 
 in figure 3 
yTD30-1a MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu-3,112 can1-100 
fob1∆::NAT-MX RPA135-F301S-TAP-HIS3 rpa49∆C(186-
416)::HPH, rDNA copy number ~25, 
+ pCJF4-LEU-GAL49 
This study 
 
RPA12-S6L in 
figures 3 
yTD31-1a MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu-3,112 can1-100 
fob1∆::NAT-MX RPA135- TAP-HIS3 RPA12-S6L-KAN-MX, rDNA 
copy number ~25, 
+ pCJF4-LEU-GAL49 
This study 
 
rpa49∆Ct RPA12-
S6L in figure 3. 
yTD23_1a MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu-3,112 can1-100 
fob1∆::NAT-MX RPA135- TAP-HIS3 RPA12-S6L-KAN-MX 
rpa49∆C(186-416)::HPHMX, rDNA copy number ~25 
This study 
 
Supplementary table 2 (continued) 
 SCOC2260 Mata ade2 arg4 leu2-3,112 trp1-289 ura3-52  
RPB6::TAP-K.L.URA3 rpa190-∆LOOP-KANMX 
This study 
 
rpa190∆loop  
in figure 4A 
yTD48-1a MATa his3∆1 leu2∆0 lys∆0 ura3∆0 rpa190∆loop::KANMX This study 
 
rpa190∆loop 
RPA135-F301S in 
figure 4A 
yTD51-2c MATalpha his3∆1 leu2∆0 met15∆0 ura3∆0 lys2∆0 
rpa190∆loop::KANMX RPA135-F301S-URA3Kl 
This study 
 
rpa190∆loop 
RPA135-F301S 
rpa49∆ in figure 4A 
yTD51-8a MATa his3∆1 leu2∆0 lys2∆0 met15∆0 ura3∆0  
RPA135-F301S-URA3Kl rpa49∆::HPHMX 
This study 
 
RPA135-F301S 
rpa49∆ in figure 4A 
yTD51-5a MATa his3∆1 leu2∆0 lys∆0 ura3∆0 RPA135-F301S-URA3Kl 
rpa49∆::HPHMX 
This study 
 
rpa49∆ in figures 4B 
and 4C 
yCN223-2a MATalpha his3∆1 leu2∆0 met15∆0 ura3∆0 lys2∆0 rpa49∆::KANMX This study 
 yTD2-3b MATa ura3∆0 his3-Δ1 leu2-Δ0 lys2-Δ0 rpa135::KANMX,  
pGL135_33 (ARS/CEN URA3 RPA135-F301S) 
This study 
 
rpa49∆  
RPA135-F301S in 
figures 4B and 4C 
yTD2-3d MATa his3∆1 leu2∆ ura3∆0 lys2∆0 rpa135∆::KANMX 
rpa49∆::HPHMX + pGL135_33 (ARS/CEN RPA135-F301S) 
This study 
rpa34∆ in figure 4B yCN224-1a MATalpha his3∆1 leu2∆0 met15∆0 ura3∆0 lys2∆0 rpa34∆::KANMX This study 
rpa34∆  
RPA135-F301S in 
figure 4B 
yTD36-2b MATalpha his3∆1 leu2∆0 ura3∆0 lys2∆0 rpa34∆::NATMX 
RPA135-F301S::URA3 
This study 
rpa34∆ rpa49∆ in 
figure 4B 
yTD37-7d MATalpha his3∆1 leu2∆0 ura3∆0 lys2∆0 rpa34∆::NATMX 
rpa49∆::HPHMX 
This study 
rpa34∆ rpa49∆ 
RPA135-F301S in 
figure 4B 
yTD37-3d MATalpha his3∆1 leu2∆0 ura3∆0 lys2∆0 rpa34∆::NATMX 
rpa49∆::HPHMX RPA135-F301S::URA3 
This study 
rpa14∆ in figure 4C yCN225-1a MATalpha his3∆1 leu2∆0 lys∆0 ura3∆0 rpa14∆:: KANMX This study 
rpa14∆  
RPA135-F301S in 
figure 4C 
yTD38-3d MATa his3∆1 leu2∆0 ura3∆0 lys2∆0 rpa14∆::NATMX 
RPA135-F301S::URA3 
This study 
rpa14∆ rpa49∆ 
RPA135-F301S in 
figure 4C 
yTD39-8a MATa his3∆1 leu2∆0 ura3∆0 lys2∆0 rpa14∆::NATMX 
rpa49∆::HPHMX RPA135-F301S::URA3 
This study 
 yTD53-1a MATalpha his3∆1 leu2∆0 lys2∆0 ura3∆0 KANMX6-pGAL::RPA12 This study 
 
RPA12 alleles in 
figure 5 with the 
plasmids indicated in 
the legend 
OGT30-1c MATa his3∆1 leu2∆0 lys∆0 ura3∆0 KANMX-pGAL::RPA12 This study 
 
rpa49∆ in figure 5 
with the plasmids 
indicated in the 
legend 
OGT30-3c MATalpha his3∆1 leu2∆0 lys∆0 ura3∆0 rpa49∆:: HPHMX  
KANMX-pGAL::RPA12 
This study 
 
 OGT30-1a MATa ura3-Δ0 his3-Δ1 leu2-Δ0 lys2-Δ0 rpa49Δ::HPH  
RPA135-(F301S)-TAP-HIS3 KANMX-pGAL::RPA12 
This study 
 
 OGT30-3a MATa ura3-Δ0 his3-Δ1 leu2-Δ0 lys2-Δ0 RPA135-(F301S)-TAP -HIS3 
KANMX-pGAL::RPA12 
This study 
 
 yTD40-1a MATa ura3-Δ0 his3-Δ1 leu2-Δ0 lys2-Δ0 RPA135-(F301S)-STOP-
URA3 KANMX-pGAL::RPA12 
This study 
 
 yTD41-1a MATa ura3-Δ0 his3-Δ1 leu2-Δ0 lys2-Δ0 rpa49Δ::HPH  
RPA135-(F301S)-STOP-URA3 KANMX-pGAL::RPA12 
This study 
 
RPA135-F301S in 
figure 5C 
yTD42-1a MATa his3∆1 leu2∆0 lys∆0 ura3∆0 RPA135-F301S::URA3  
KANMX-pGAL::RPA12 
This study 
 
rpa49∆  
RPA135-F301S  
in figure 5C 
yTD43-1a MATalpha his3∆1 leu2∆0 lys∆0 ura3∆0 rpa49∆:: HPHMX  
RPA135-F301S::URA3 KANMX-pGAL::RPA12 
This study 
 
rrp6∆ in figure 7 and 
S5 
yCD2-2a MATa his3∆1 leu2∆0 ura3∆ met15∆0 rrp6::NAT  This study 
 yMKS8-1a MATa his3∆1 leu2∆0 ura3∆ met15∆0 rrp6::NAT KANMX6-
pGAL::RPA49 
This study 
Rpa135-F301S rrp6∆ 
in figure 7 and S5 
yMKS9-9d MATa his3∆1 leu2∆0 ura3∆ rrp6::NAT RPA135-F301S-TAP-HIS3 This study 
Supplementary table 3: Plasmids used in this study 
 
Name Description Source 
pUC19-HPH Plasmid bearing HPH-MX4 [55] 
pFA6-kanMX6 Plasmid bearing KAN-MX6 [56] 
pFA6a-KanMX6-
GAL::3HA 
Plasmid used for GAL promoter insertion [56] 
pFA6a-HA-KlURA3 Plasmid used for epitope switching [57] 
pNOY80 Plasmid CEN6 ARS4, URA3, RPA135  [58] 
pVV190 Plasmid pFL44-A190 (2µ URA3 RPA190)  [24] 
pRS316 CEN6 ARS4, URA3 [59] 
pCR4-HIS3 HIS3 [59] [60] 
pGL190_3  (2µ URA3 RPA190-E1274K) selected from randomly mutagenized pVV190 This study 
pGL190_11  (2µ URA3 RPA190- C1493R) selected from randomly mutagenized pVV190 This study 
pGL190_23  (2µ URA3 RPA190- L1262P) selected from randomly mutagenized pVV190 This study 
pGL135_6prim  (CEN4 URA3 RPA135-R379G selected from randomly mutagenized pNOY80 This study 
pGL135_54   (CEN4 URA3 RPA135-Y252H) selected from randomly mutagenized pNOY80 This study 
pGL135_33 (CEN4 URA3 RPA135-F301S) selected from randomly mutagenized pNOY80 This study 
pTD1_3b_135TAP Plasmid pNOY80 bearing RPA135-TAP-HIS3 obtained by homologous 
recombination using a PCR-amplified fragment generated with oligos 835 and 
836 and genomic DNA of strain 202233825 as template. 
This study 
pTD2_6c_135TAP Plasmid pNOY80 bearing RPA135-F301S-TAP-HIS3 obtained by homologous 
recombination using a PCR-amplified fragment generated with oligos 835 and 
836 and genomic DNA of strain 202233825 as template. 
This study 
pTD5 Plasmid pTD1_3b_135TAP deleted of URA3 using NsiI and SdaI digestion 
and self-ligation.  
This study 
pTD6 Plasmid pTD2_6c_135TAP deleted of URA3 using NsiI and SdaI digestion 
and self-ligation. 
This study 
Ycp50-26 URA3 ARS/CEN RPA49  [59] 
pRS316-A12 pRS316 vector ligated with a PCR-generated fragment using oligos 1554 and 
1555 and yeast genomic DNA as template cut BamHI-XbaI, and cloned at 
same site. 
This study 
pRS316-A12-AvrII PCR mediated mutagenesis to introduce AvrII site in pRS316-A12 using 
oligos 1714 and 1715. 
This study 
pRS316-A12-S6L S6L Allele of RPA12 isolated as a suppressor of the rpa49∆ growth defect, 
selected from a PCR-mediated random mutagenesis of pRS316-A12-AvrII. 
This study 
pRS316-A12-S6L-KAN Plasmid obtained using pRS316-A12-S6L modified by homologous 
recombination using a PCR-amplified fragment generated with oligos 1682 
and 1559 and pFA6-kanMX6 as template. 
This study 
pRS316-A12-T49A T49A Allele of RPA12 isolated as a suppressor of the rpa49∆ growth defect, 
selected from a PCR mediated random mutagenesis of pRS316-A12-AvrII. 
This study 
pRS316-A12-DCt Plasmid obtained using pRS316-A12 modified by homologous recombination 
using a PCR-amplified fragment generated with oligos 1371 and 1559 and 
pFA6-kanMX6 as template. 
This study 
pTD9 Plasmid obtained using pRS316-A12-T49A modified by homologous 
recombination using a PCR-amplified fragment generated with oligos 1371 
and 1559 and pFA6-kanMX6 as template. 
This study 
pTD10 Plasmid obtained using pRS316-A12-S6L modified by homologous 
recombination using a PCR-amplified fragment generated with oligos 1371 
and 1559 and pFA6-kanMX6 as template. 
This study 
pCJPF4 pFL36cII with LEU2 marker, CEN4, containing RPA49 coding region This study 
pCJPF4-GAL49-1 Plasmid obtained using pCJPF4 modified by homologous recombination using 
a PCR-amplified fragment generated with oligos 624 and 625 and pFA6a-
KanMX6-GAL::3HA as template.  
This study 
pMAX1 Plasmid including Pol I promoter used for in vitro assays [23] 
pUC19tail_g-
_601_elongated 
 
Plasmid used for tailed template [61] 
 
 
 
 
 
 
Supplementary table 4: Oligonucleotides used in this study 
Sequence N° 
gctgctttatagaaccatctagcaaaaaaaaaaaccagagcaaaccaaatgctcagtatatacctctaggtaactgaattcgagctcgtttaaac 208 
aaagcagttgaagacaagttcgaa 301 
gactctctccaccgtttgacg 302 
ggtctgtgatgcccttagacg 307 
agtttcacaagattaccaagacctctc 308 
ggtggtaaattccatctaaagctaaatatt 311 
cacgtactttttcactctcttttcaaa 312 
ccactattgcagtcgttatcaaccttttgcactttatctagtagaattcgagctcgtttaaac 624 
cactttcaatttcgatttcagaaacagaccttttcacggacattttgagatccgggtttt 625 
catagtttctggcatgaccc 649 
gaagaatcctggtagtatgg 650 
tcgatgaattcgagctcgt 700 
gtcttcaactgctttcgcat 774 
gacgctgatgacatcgagtg 835 
tgatgggcacatatgaagtc 836 
catggcttaatctttgagac 892 
aggttctaacgttaatgtttctcaa 1189 
actttataataccctagctctctta 1194 
aagtcacaattctccaatttaaaagtcgtcaccacgacggcagacgatgcgtttccatcttctcttagagccaagaaatgaggcgcgccacttctaaa 1371 
ccatcgaaagttgatagggcag 1501 
ctacgttcgacttatacaaaaaaaagaagtctgaaaaggacgaattcgtattacacggtgaaaacgagagactagaataccggatccccgggttaattaa 1515 
gggggatcctttcaaatattgctataaaaatggatgatagc 1554 
cgctctagacactgaatgtcacgatagagttatc 1555 
cactgaatgtcacgatagagttatcgctgt 1556 
tttcaaatattgctataaaaatggatgata 1557 
tctatagatgttcacatgatgaaagcggggatgatattaatgtacaaattgtaatatgtgcgaacacaacccaatcagaattcgagctcgtttaaac 1559 
ctaatacggcattaggattttccaggagatcaccacagtccaagcaaaaaattaacgatcctacaacagacattttgagatccgggtttt 1634 
tttatgtcaagtgaagggcattgcatggcaagtgtaaagaatccaagaaggaattcgagctcgtttaaac 1635 
agttaagatctgcagatgaaggtgctactgtcttctatacatgcacttcctgtggttacaagttccgtaccaacaattgatgaggcgcgccacttctaaa 1682 
ttgaagtacttggactctgagctatccgcaatgggtataagattgcgttataatgtagagcccaaataacggatccccgggttaattaa 1679 
gatctcctggaaaatcctaatgccgtcctaggctctaacgttgaatgcagcc 1714 
ggctgcattcaacgttagagcctaggacggcattaggattttccaggagatc 1715 
gatttgtttaacggcttctttgtagtcatcctgctgttgtttttgtatgtttaagcttcttcctccgattaagttttgtacatgtaaaacgacggccagt 1716 
tgatgcttttttgaagttttcatggcatgatttagcatttgaaatataatgagaaaagagccctttaacttacagaagtaaggaaacagctatgaccatg 1717 
ttcttgcatgaacactaatgatattaggagggctttttaagttgctaccagaattcgagctcgtttaaac 1711 
cactttcaatttcgatttcagaaacagaccttttcacggacatgcactgagcagcgtaatctg 1713 
ctccgcttattgatatgc 1829 
tgagaaggaaatgacgct 1830 
accgtttggtctacccaagtgagaagccaagaca 1831 
atcccggccgcctccatcac 1832 
cggttttaattgtccta 1833 
cctacagcgtgagctatgagaaag 1834 
tcaccttaccctatacttactcg 1835 
aaatggcctatcggaatacattttctacatcctaactactataaaacaacctttagacttacgtttgctactctcatggt 1855 
tgcgaccggctattcaacaaggcattcccccaagtttgaattctttgaaatagattgctattagctagtaatccaccaaa 1857 
ggaattcctcgttgaagagcaataattacaatgctctatccccagcacgacggagtttcacaagattaccaagacctctc 1859 
gtgctggcctcttccagccataagaccccatctccggataaaccaattccggggtgataagctgttaagaagaaaagata 1860 
gtaaatggtacactcttacacactatcatcctcatcgtatattataatagatatatacaatacatgtttttacccggatc 1861 
tccgggcaaatcctttcacgctcgggaagctttgtgaaagcccttctctttcaacccatctttgcaacgaaaaaaaaaaa 1862 
cagcttaactacagttgatcggacgggaaacggtgctttctggtagatatggccgcaaccgatagtttaacggaaacgca 1863 
aaaaaaaaaaaagaaataaagattgcagcacctgagtttcgcgtatggtcacccactacactactcggtcaggctcttac 1864 
 
 
